Nanotechnology‐enhanced radiotherapy and the abscopal effect: Current status and challenges of nanomaterial‐based radio‐immunotherapy
WIREs Nanomedicine and Nanobiotechnology · 2024-01 · 16 (1)
DOI: 10.1002/wnan.1924 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, online erschienen am 25.08.2023. Verfasst von Dhushyanth Viswanath und 6 weiteren Autor:innen. Beteiligte Einrichtung: Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana, USA. Hauptthemen laut MEDLINE: Neoplasms, Nanostructures. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: National Science Foundation, Purdue University Institute for Cancer Research (PU-ICR), Davidson School of Chemical Engineering at Purdue University.
Abstract (Originalsprache)
Rare but consistent reports of abscopal remission in patients challenge the notion that radiotherapy (RT) is a local treatment; radiation‐induced cancer cell death can trigger activation and recruitment of dendritic cells to the primary tumor site, which subsequently initiates systemic immune responses against metastatic lesions. Although this abscopal effect was initially considered an anomaly, combining RT with immune checkpoint inhibitor therapies has been shown to greatly improve the incidence of abscopal responses via modulation of the immunosuppressive tumor microenvironment. Preclinical studies have demonstrated that nanomaterials can further improve the reliability and potency of the abscopal effect for various different types of cancer by (1) altering the cell death process to be more immunogenic, (2) facilitating the capture and transfer of tumor antigens from the site of cancer cell death to antigen‐presenting cells, and (3) co‐delivering immune checkpoint inhibitors along with radio‐enhancing agents. Several unanswered questions remain concerning the exact mechanisms of action for nanomaterial‐enhanced RT and for its combination with immune checkpoint inhibition and other immunostimulatory treatments in clinically relevant settings. The purpose of this article is to summarize key recent developments in this field and also highlight knowledge gaps that exist in this field. An improved mechanistic understanding will be critical for clinical translation of nanomaterials for advanced radio‐immunotherapy. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana, USA.
- SOFT Foundry Institute, Seoul National University, Seoul, Republic of Korea.
- Analytical Sciences, Sanofi, Toronto, Ontario, Canada.
- Department of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
- Department of Materials Science and Engineering, Institute of Engineering Research, BioMAX, Seoul National University, Seoul, Republic of Korea.
- Purdue University Institute for Cancer Research, Purdue University, West Lafayette, Indiana, USA.
ORCID-Profile: Vincenzo J Pizzuti, You-Yeon Won
Förderung
- National Science Foundation
- Purdue University Institute for Cancer Research (PU-ICR)
- Davidson School of Chemical Engineering at Purdue University
- National Research Foundation of Korea under the Korean Ministry of Science and ICT (MSIT)
- Seoul National University
- Davidson School of Chemical Engineering, Purdue University
- Ministry of Science and ICT, South Korea
Zitieren
APA
Viswanath, D., Park, J., Misra, R., Pizzuti, V. J., Shin, S. H., Doh, J., & Won, Y. Y. (2024). Nanotechnology‐enhanced radiotherapy and the abscopal effect: Current status and challenges of nanomaterial‐based radio‐immunotherapy. WIREs Nanomedicine and Nanobiotechnology, 16(1). https://doi.org/10.1002/wnan.1924
Vancouver
Viswanath D, Park J, Misra R, Pizzuti VJ, Shin SH, Doh J, et al. Nanotechnology‐enhanced radiotherapy and the abscopal effect: Current status and challenges of nanomaterial‐based radio‐immunotherapy. WIREs Nanomedicine and Nanobiotechnology. 2024;16(1). doi:10.1002/wnan.1924
BibTeX
@article{Viswanath2024,
author = {Viswanath, Dhushyanth and Park, Jeehun and Misra, Rahul and Pizzuti, Vincenzo J and Shin, Sung-Ho and Doh, Junsang and Won, You-Yeon},
title = {Nanotechnology‐enhanced radiotherapy and the abscopal effect: Current status and challenges of nanomaterial‐based radio‐immunotherapy},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2024},
volume = {16},
number = {1},
doi = {10.1002/wnan.1924}
}
EUVIMED